Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S.
Guardant Health, Inc. (GH)
Last guardant health, inc. earnings: 2/24 04:03 pm
Check Earnings Report
Company Research
Source: Business Wire
Partnership integrates Guardant’s large-scale genomic data with Trial Library’s AI-powered matching and navigation platform to expand equitable access to oncology clinical trials across the United StatesCollaboration seeks to broaden trial access for representative and underserved patient populations by uniting genomic insights with personalized navigation and support services PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health (Nasdaq: GH), a leading precision oncology company, and Trial Library, an AI technology company enabling oncology clinical trials as a care option, today announced a strategic collaboration to increase access to cancer clinical trials in the United States.The collaboration combines Guardant Health’s suite of cutting-edge precision oncology diagnostics with Trial Library’s AI-powered matching and patient navigation platform. Together, the companies aim to streamline the identification, referral, and enrollment of patients into precision oncology clinical tria
Show less
Read more
Impact Snapshot
Event Time:
GH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GH alerts
High impacting Guardant Health, Inc. news events
Weekly update
A roundup of the hottest topics
GH
News
- Guardant Health (NASDAQ:GH) had its price target raised by analysts at BTIG Research from $100.00 to $140.00. They now have a "buy" rating on the stock.MarketBeat
- Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S. [Yahoo! Finance]Yahoo! Finance
- Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..MarketBeat
- Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in ItalyBusiness Wire
- Hammerspace Helps Launch the Single Namespace Working Group (SNS) to End Data Fragmentation and Expose a Single, Unified Intelligence Layer for DataPR Web
GH
Earnings
- 10/29/25 - Beat
GH
Sec Filings
- 12/10/25 - Form 4
- 12/10/25 - Form 4
- 12/10/25 - Form 4
- GH's page on the SEC website